AUTL

Autolus Therapeutics
AUTL

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$10
619% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Needham
Needham
Gil Blum
25% 1-yr AUTL win rate
3 Nov ‘25 29 days ago